Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Vanguard drops hyperphosphatemia Rx from development pipeline

Dec. 16, 1998

Fujisawa describes potential new agent for treating BPH

Dec. 8, 1998

Pharmacokinetic studies support chronic dosing of FK-143

Dec. 3, 1998

Health Canada approves first new incontinence medication in over a decade

Dec. 3, 1998

Tamsulosin improves signs and symptoms of BPH in phase III study

Dec. 1, 1998

Pfizer claims new series for BPH with selective prostatic alpha1-adrenoceptor-antagonist effects

Dec. 1, 1998

Japanese researchers present positive findings in Synsorb Pk trial

Nov. 27, 1998

New treatment for aldosterone-related disorders discovered by French research team

Nov. 24, 1998

Dual 5alpha-reductase inhibitors and alpha1-blocking agents prepared at Zeria

Nov. 23, 1998

Agents for nephritis in the Tsumura pipeline

Nov. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...